Showing results (1-10 of 268) with videos related to
Sort By:
Pageof 27
Handbook of Experimental Pharmacology|April 13, 2011
Overcoming insulin resistance with ciliary neurotrophic factorTamara L Allen, Vance B Matthews, Mark A FebbraioJournal of Molecular Medicine (Berlin, Germany)|January 23, 2008
CNTF: a target therapeutic for obesity-related metabolic disease?Vance B Matthews, Mark A FebbraioCell Metabolism|January 10, 2012
IL-6 muscles in on the gut and pancreas to enhance insulin secretionTamara L Allen, Martin Whitham, Mark A FebbraioExperimental Physiology|September 15, 2009
Role of exercise-induced brain-derived neurotrophic factor production in the regulation of energy homeostasis in mammalsBente K Pedersen, Maria Pedersen, Karen S Krabbe, et al.Trends in Endocrinology and Metabolism: TEM|April 5, 2014
Role of interleukins in obesity: implications for metabolic diseaseMark A FebbraioExercise Immunology Review|December 23, 2003
Signaling pathways for IL-6 within skeletal muscleMark A FebbraioThe Journal of Clinical Investigation|April 4, 2007
gp130 receptor ligands as potential therapeutic targets for obesityMark A FebbraioDiabetes|May 15, 2013
Interleukin-18 activates skeletal muscle AMPK and reduces weight gain and insulin resistance in miceBirgitte Lindegaard, Vance B Matthews, Claus Brandt, et al.Diabetes|February 4, 2009
Interleukin-6 attenuates insulin-mediated increases in endothelial cell signaling but augments skeletal muscle insulin action via differential effects on tumor necrosis factor-alpha expressionDerek Y C Yuen, Renee M Dwyer, Vance B Matthews, et al.Pageof 27